We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
Chinese consumers, once the engine of growth for multinational companies, are cutting back on all kinds of things. Designer ...
The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority ...
Its monotherapy drug that is used to treat desmoid tumors has been approved in the United States. A transaction for Springworks would rank as one of the biggest pharma deals for Merck in recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results